Kim Davis started taking the weight loss drug Zepbound in 2024 and saw success. However, she lost insurance coverage for the ...

At least 12% of adults in the U.S. have been prescribed a glucagon‐like peptide‐1 drug for one or multiple indications, but ...

Today, the compounded GLP-1 market is in upheaval. The FDA has banned copies of GLP-1 weight loss drugs, and a number of ...

WASHINGTON (AP) — President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for the popular obesity treatments Zepbound and Wegovy ...

This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Weight loss drugs can cost $200 to $2,000 monthly, depending on the medication. The cost of weight loss drugs also varies depending ...

Tirzepatide can cost $500 to $1,900 a month without insurance. More affordable tirzepatide alternatives include semaglutide, ...

Medicare beneficiaries could see out-of-pocket prescription drug costs cut by more than half in 2026, according to a new AARP ...

The deals tout significant discounts for people who pay out of pocket for certain medications. But most people with insurance ...

Even when Americans have health insurance, they can have a hard time affording the drugs they’ve been prescribed.

President Donald Trump has announced a new agreement with drugmakers Eli Lilly and Novo Nordisk aimed at expanding access and lowering the cost of their blockbuster obesity drugs, Zepbound and Wegovy.

A new report indicates that U.S. drugmakers will raise prices on at least 350 medications despite pressure from President ...